A prospective study showing an excellent response of patients with low-risk differentiated thyroid cancer who did not undergo radioiodine remnant ablation after total …

CCPS Janovsky, RMB Maciel… - European thyroid …, 2016 - etj.bioscientifica.com
Objectives: To prospectively evaluate the outcome of patients with low-risk papillary thyroid
carcinoma treated with total thyroidectomy (TT) who did not undergo radioiodine remnant …

Multidisciplinary approach for risk-oriented treatment of low-risk papillary thyroid cancer in Switzerland

H Zulewski, L Giovanella, S Bilz, E Christ… - Swiss medical …, 2019 - smw.ch
After the update of the American Thyroid Association (ATA) guidelines on diagnosis and
treatment of patients with thyroid cancer in 2015 [1], it became evident that, for patients with …

A systematic review of primary active surveillance management of low-risk papillary carcinoma

A Alhashemi, DP Goldstein… - Current opinion in …, 2016 - journals.lww.com
A systematic review of primary active surveillance managemen... : Current Opinion in Oncology
A systematic review of primary active surveillance management of low-risk papillary carcinoma …

Lysine-specific demethylase 1 affects the progression of papillary thyroid carcinoma via HIF1α and microRNA-146a

M Long, Y Zhu, Z Chen, S Lin, X Peng… - The Journal of …, 2020 - academic.oup.com
Context Lysine-specific demethylase 1 (LSD1) stabilizes hypoxia-inducible factor 1α (HIF1α)
to advance tumor progression, while HIF1α functions as a transcription factor to increase the …

XBP1s Acts as a Tumor Suppressor to Inhibit the EMT Process and Metastasis of Papillary Thyroid Cancer

W Yang, X Xu, M Xu, J Zhou, Z Xi, H Guo… - OncoTargets and …, 2021 - Taylor & Francis
Purpose Papillary thyroid cancer (PTC) patients could obtain poor prognosis if they have
lymph node metastasis, identification of informative and robust biomarkers for predicting …

Evolutionary features of thyroid cancer in patients with thyroidectomies from 2008 to 2013 in China

X Liu, L Zhu, Z Wang, D Cui, H Chen, Y Duan… - Scientific Reports, 2016 - nature.com
To evaluate the characteristics of thyroid carcinoma over time, we carried out a retrospective
study to illustrate the evolutionary features of thyroid carcinoma. All records of …

Prediction of TNFRSF9 expression and molecular pathological features in thyroid cancer using machine learning to construct Pathomics models

Y Liu, J Zhang, S Li, W Chen, R Wu, Z Hao, J Xu - Endocrine, 2024 - Springer
Background The TNFRSF9 molecule is pivotal in thyroid carcinoma (THCA) development.
This study utilizes Pathomics techniques to predict TNFRSF9 expression in THCA tissue and …

[HTML][HTML] A novel self-assemble peptide drug design of AKT1 for anaplastic thyroid cancer therapy

L Chai, Z Qiu, X Zhang, R Li, K Wang - Biochemical and Biophysical …, 2022 - Elsevier
Anaplastic thyroid cancer (ATC) is an undifferentiated subtype of thyroid cancer with a
markedly poor survival prognosis, estimated to occur 3–5 months after diagnosis. Akt …

[HTML][HTML] LINC01087 promotes the proliferation, migration, and invasion of thyroid cancer cells by upregulating PPM1E

Y Yin, J Huang, H Shi, Y Huang, Z Huang, M Song… - Journal of …, 2022 - hindawi.com
This study is aimed at investigating the effect and mechanism of LINC01087 on the
malignant evolution of thyroid cancer cells. The expression levels of LINC01087, miR-135a …

Magnetic resonance imaging in the prediction of aggressive histological features in papillary thyroid carcinoma

B Song, H Wang, Y Chen, W Liu, R Wei, Z Dai, W Hu… - Medicine, 2018 - journals.lww.com
Magnetic resonance imaging in the prediction of aggressive h... : Medicine Magnetic resonance
imaging in the prediction of aggressive histological features in papillary thyroid carcinoma …